Your browser doesn't support javascript.
Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients.
Ashwin, Helen; Milross, Luke; Wilson, Julie; Majo, Joaquim; Hang Lee, Jimmy Tsz; Calder, Grant; Hunter, Bethany; James, Sally; Lagos, Dimitris; Signoret, Nathalie; Filby, Andrew; Bayraktar, Omer Ali; Fisher, Andrew J; Kaye, Paul M.
  • Ashwin H; York Biomedical Research Institute, Hull York Medical School, University of York, York, UK.
  • Milross L; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.
  • Wilson J; Department of Mathematics, University of York, York, UK.
  • Majo J; Department of Cellular Pathology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • Hang Lee JT; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • Calder G; Biosciences Technology Facility, University of York, York, UK.
  • Hunter B; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.
  • James S; Biosciences Technology Facility, University of York, York, UK.
  • Lagos D; York Biomedical Research Institute, Hull York Medical School, University of York, York, UK.
  • Signoret N; York Biomedical Research Institute, Hull York Medical School, University of York, York, UK.
  • Filby A; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Bayraktar OA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • Fisher AJ; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK paul.kaye@york.ac.uk a.j.fisher@newcastle.ac.uk.
  • Kaye PM; Institute of Transplantation, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
J Clin Pathol ; 2023 Mar 09.
Article in English | MEDLINE | ID: covidwho-2250385
ABSTRACT
Diffuse alveolar damage (DAD) is the histological expression of acute respiratory distress syndrome and characterises lung pathology due to infection with SARS-CoV-2, and other respiratory pathogens of clinical significance. DAD reflects a time-dependent immunopathological process, progressing from an early/exudative stage through to an organising/fibrotic stage, yet within an individual these different stages of DAD may coexist. Understanding the progression of DAD is central to the development of new therapeutics to limit progressive lung damage. Here, we applied highly multiplexed spatial protein profiling to autopsy lung tissues derived from 27 patients who died from COVID-19 and identified a protein signature (ARG1, CD127, GZMB, IDO1, Ki67, phospho-PRAS40 (T246) and VISTA) that distinguishes early DAD from late DAD with good predictive accuracy. These proteins warrant further investigation as potential regulators of DAD progression.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Year: 2023 Document Type: Article Affiliation country: Jcp-2023-208771

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Year: 2023 Document Type: Article Affiliation country: Jcp-2023-208771